Betacetylmethadol

This classification denotes an opioid receptor agonist with the molecular formula C23H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 905GLN509G, chemically known as 3-heptanol, 6-(dimethylamino)-4,4-diphenyl-, acetate (ester), (3r,6r)-(-)- but generally known as betacetylmethadol, which bears US NIH Compound Identifier 62710. European Medicines Agency schedules Betacetylmethadol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05792MIG. The term BETACETYLMETHADOL is an International Non-Proprietary Name. BETACETYLMETHADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule betacetylmethadol under HS 29221980 and SITC 51461. As of Q4 2014, BETACETYLMETHADOL remains the US FDA Preferred Term for this commodity. Betacetylmethadol bears US NLM identifiers UMLS ID C2698377 and NCI Concept Code C77278. SMILES: O(C(C(CC(N(C)C)C)(C1CCCCC1)C1CCCCC1)CC)C(=O)C.